465 related articles for article (PubMed ID: 30112998)
1. Mesenchymal Stem Cells, Immune Cells and Tumor Cells Crosstalk: A Sinister Triangle in the Tumor Microenvironment.
Razmkhah M; Abtahi S; Ghaderi A
Curr Stem Cell Res Ther; 2019; 14(1):43-51. PubMed ID: 30112998
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stem Cells in the Tumor Microenvironment.
Atiya H; Frisbie L; Pressimone C; Coffman L
Adv Exp Med Biol; 2020; 1234():31-42. PubMed ID: 32040853
[TBL] [Abstract][Full Text] [Related]
3. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cells: Key Actors in Tumor Niche.
El Marsafy S; Larghero J
Curr Stem Cell Res Ther; 2015; 10(6):523-9. PubMed ID: 26216129
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells: key players in cancer progression.
Ridge SM; Sullivan FJ; Glynn SA
Mol Cancer; 2017 Feb; 16(1):31. PubMed ID: 28148268
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan: A modulator of the tumor microenvironment.
Chanmee T; Ontong P; Itano N
Cancer Lett; 2016 May; 375(1):20-30. PubMed ID: 26921785
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
O'Malley G; Heijltjes M; Houston AM; Rani S; Ritter T; Egan LJ; Ryan AE
Oncotarget; 2016 Sep; 7(37):60752-60774. PubMed ID: 27542276
[TBL] [Abstract][Full Text] [Related]
8. Current perspectives on the crosstalk between lung cancer stem cells and cancer-associated fibroblasts.
Alguacil-Núñez C; Ferrer-Ortiz I; García-Verdú E; López-Pirez P; Llorente-Cortijo IM; Sainz B
Crit Rev Oncol Hematol; 2018 May; 125():102-110. PubMed ID: 29650269
[TBL] [Abstract][Full Text] [Related]
9. The Roles of Mesenchymal Stromal/Stem Cells in Tumor Microenvironment Associated with Inflammation.
Trivanović D; Krstić J; Djordjević IO; Mojsilović S; Santibanez JF; Bugarski D; Jauković A
Mediators Inflamm; 2016; 2016():7314016. PubMed ID: 27630452
[TBL] [Abstract][Full Text] [Related]
10. Whom to blame for metastasis, the epithelial-mesenchymal transition or the tumor microenvironment?
Pietilä M; Ivaska J; Mani SA
Cancer Lett; 2016 Sep; 380(1):359-68. PubMed ID: 26791236
[TBL] [Abstract][Full Text] [Related]
11. The Multifunction Role of Tumor-Associated Mesenchymal Stem Cells and Their Interaction with Immune Cells in Breast Cancer.
Chauhan A; Agarwal S; Masih M; Gautam PK
Immunol Invest; 2023 Nov; 52(7):856-878. PubMed ID: 37615117
[TBL] [Abstract][Full Text] [Related]
12. Involvement of mesenchymal stem cells in cancer progression and metastases.
Chang AI; Schwertschkow AH; Nolta JA; Wu J
Curr Cancer Drug Targets; 2015; 15(2):88-98. PubMed ID: 25619387
[TBL] [Abstract][Full Text] [Related]
13. Roles of cell fusion between mesenchymal stromal/stem cells and malignant cells in tumor growth and metastasis.
Zhang LN; Zhang DD; Yang L; Gu YX; Zuo QP; Wang HY; Xu J; Liu DX
FEBS J; 2021 Mar; 288(5):1447-1456. PubMed ID: 33070450
[TBL] [Abstract][Full Text] [Related]
14. Interplay between mesenchymal stem cell and tumor and potential application.
Wang Q; Li T; Wu W; Ding G
Hum Cell; 2020 Jul; 33(3):444-458. PubMed ID: 32378164
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cells and Cancer Stem Cells: An Overview of Tumor- Mesenchymal Stem Cell Interaction for Therapeutic Interventions.
Montazersaheb S; Fathi E; Mamandi A; Farahzadi R; Heidari HR
Curr Drug Targets; 2022; 23(1):60-71. PubMed ID: 34431459
[TBL] [Abstract][Full Text] [Related]
16. Carcinoma-Associated Mesenchymal Stem/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment.
Frisbie L; Buckanovich RJ; Coffman L
Stem Cells; 2022 Aug; 40(8):705-715. PubMed ID: 35583414
[TBL] [Abstract][Full Text] [Related]
17. The cancer stem cell niche: cross talk between cancer stem cells and their microenvironment.
Ye J; Wu D; Wu P; Chen Z; Huang J
Tumour Biol; 2014 May; 35(5):3945-51. PubMed ID: 24420150
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting.
Sistigu A; Di Modugno F; Manic G; Nisticò P
Cytokine Growth Factor Rev; 2017 Aug; 36():67-77. PubMed ID: 28595838
[TBL] [Abstract][Full Text] [Related]
19. Immune modulation by a cellular network of mesenchymal stem cells and breast cancer cell subsets: Implication for cancer therapy.
Eltoukhy HS; Sinha G; Moore CA; Sandiford OA; Rameshwar P
Cell Immunol; 2018 Apr; 326():33-41. PubMed ID: 28779846
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells as a double-edged sword in tumor growth: focusing on MSC-derived cytokines.
Liang W; Chen X; Zhang S; Fang J; Chen M; Xu Y; Chen X
Cell Mol Biol Lett; 2021 Jan; 26(1):3. PubMed ID: 33472580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
